Alcohol-Associated Hepatitis and Early Liver Transplantation
OverviewThis activity reviews the diagnosis and management of alcohol-associated liver disease (ALD) and alcohol-associated hepatitis (AAH), including alcohol cessation strategies, treatment of alcohol use disorder, appropriate use of corticosteroids, and the evolving role of early liver transplantation. Learners will gain practical guidance on risk stratification, treatment thresholds, and timely referral of patients with severe alcohol-associated liver disease.
RegistrationRegistration for all practitioners - free.
To register for this activity, please click HERE
CreditsAMA PRA Category 1 Credits™ (1.00 hours), AAPA Category 1 CME credits (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Participation Credit (1.00 hours)
Target AudienceSpecialties - Family Medicine & Community Health, Gastroenterology, Gastroenterology & Hepatology, Hematology, Internal MedicineProfessions - Advance Practice Nurse (APN), Non-Physician, Nurse, Physician, Physician Associate, Registered Nurse (RN) ObjectivesAt the conclusion of this activity, learners should be able to:
1. Apply NIAAA clinical criteria and phosphatidylethanol testing to accurately diagnose alcohol-associated hepatitis and distinguish alcohol-associated liver disease from MASLD.
2. Use MELD rather than the Maddrey discriminant function to risk-stratify patients with alcohol-associated hepatitis and identify candidates for corticosteroid therapy.
3. Manage corticosteroid therapy appropriately, including assessment of contraindications and calculation of the Lille score at day 4 or 7 to discontinue treatment in non-responders.
4. Initiate concurrent treatment of alcohol use disorder using behavioral support and evidence-based pharmacotherapy, avoiding agents contraindicated in liver disease.
5. Identify patients appropriate for early liver transplant referral without applying a fixed 6-month sobriety interval, and document eligibility using specific, non-stigmatizing language.
AccreditationIn support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
Stanford Medicine designates this Live Activity for a maximum of 1.00 ANCC contact hours.
American Academy of Physician Associates (AAPA) - Live
Stanford Medicine has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This live activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.